diarrhea

In short, Infliximab is a TNF-alpha inhibitor used to reduce inflammation and control Crohn’s disease. Clinical studies show that infliximab and biosimilars like Renflexis are effective in inducing and maintaining remission. Ongoing monitoring is important to ensure safety and long-term success. Understanding Crohn’s Disease and the Role of Infliximab Crohn’s disease is a chronic inflammatory

Read More